Affiliations: Child Neuropsychiatric Unit, Department of
Neuroscience, University of Parma, Italy
Note: [] Correspondence: Dr. Francesco Pisani, Department of
Neuroscience, Via Gramsci, 14, 43100 Parma, Italy. Tel.: +39 0521 702750; Fax:
+39 0521 290458; E-mail: francesco.pisani@unipr.it
Abstract: Intrathecal therapy with methotrexate and cytosine-arabinoside is a
therapeutic strategy for maintaining remission in patients with acute
lymphoblastic leukemia, that is associated with neurological side effects are
described. We report a 4-year-old girl who became tetraplegic after the last
dose of intrathecal therapy. Cerebrospinal fluid showed elevated protein level
and nerve conduction study revealed a motor neuronopathy. Spine magnetic
resonance imaging revealed gadolinium enhancement of the anterior roots of the
cauda equina. We describe a myelopathy confined to the anterior horns and
anterior spinal nerve roots without sensory involvement caused by intrathecal
methotrexate. The pathogenesis of this selective involvement remains
uncertain.
Keywords: Intrathecal methotrexate, acute lymphocytic leukemia, motor neuronopathy, ventral polyradiculopathy